Moderna
MRNA
#257
Rank
NZ$168.68 B
Marketcap
NZ$416.89
Share price
-6.97%
Change (1 day)
783.78%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$168.68 Billion

As of November 2026 Moderna has a market cap of NZ$168.68 Billion. This makes Moderna the world's 257th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$168.68 B701.36%
2025NZ$21.04 B-23.13%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Nov 12th, 2026 the market cap of Moderna was reported to be:

NZ$168.68 Billion
by Nasdaq info icon info icon
NZ$168.68 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.229 T 629.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$545.37 B 223.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$652.80 B 287.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ$1.01 B-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.36 B-96.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$1.5 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$37.80 B-77.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$12.00 B-92.89%๐Ÿ‡บ๐Ÿ‡ธ USA